<?xml version="1.0" encoding="UTF-8"?>
<p>Supporting this, a Sanofi Pasteur integrated immunogenicity analysis across 10 phase II and 6 phase III trials undertaken in dengue endemic and non-endemic countries confirmed that Geometric Mean Titers (GMTs) were positively influenced by baseline dengue seropositivity: participants who were seropositive to at least one dengue serotype at baseline in general achieved higher post-dose 3 GMTs for all serotypes than those who were seronegative regardless of the region [
 <xref rid="B36-vaccines-08-00174" ref-type="bibr">36</xref>].
</p>
